Table 2. LPA concentration in pleural effusion of lung cancer patients.
| Clinical variables | No. of patients | LPA (μg/L), mean ± SD | P value |
|---|---|---|---|
| Age (years) | 0.41 | ||
| ≥60 | 56 | 20.68±9.30 | |
| <60 | 38 | 21.20±7.84 | |
| Gender | 0.789 | ||
| Male | 55 | 21.87±8.10 | |
| Female | 39 | 22.48±9.63 | |
| Smoke condition | 0.838 | ||
| Smoke | 47 | 22.27±8.03 | |
| Non-smoke | 47 | 21.90±9.44 | |
| Histologic type | 0.603 | ||
| Adenocarcinoma | 74 | 22.01±9.28 | |
| Squamous cell carcinoma | 12 | 20.76±4.65 | |
| Small cell lung cancer | 8 | 24.75±8.19 | |
| Cytologic examination | 0.234 | ||
| Positive | 28 | 24.10±11.68 | |
| Negative | 66 | 21.23±11.68 |
LPA, lysophosphatidic acid.